CF
PFE icon

Cantor Fitzgerald’s Pfizer PFE Stock Holding History

Cantor Fitzgerald’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-20,000
Closed -$485K – 499
2025
Q2 		$485K Buy
+20,000
New +$466K 0.01% 235
2024
Q2 		– Sell
-50,000
Closed -$21.8K – 308
2024
Q1 		$21.8K Buy
+50,000
New +$1.39M 0.01% 207

Other funds holding PFE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Cantor Fitzgerald's PFE Position: Q3 2025 in Review

Cantor Fitzgerald sold out of Pfizer (PFE) in Q3 2025, closing a stake of 688 shares — an estimated $16.7K sold.

Cantor Fitzgerald first reported a position in PFE in Q2 2022 and held it in 7 quarters. The position peaked at $64.1M in Q2 2022. 2,811 funds tracked by Wall St. Rank hold PFE as of Q3 2025.

  • Cantor Fitzgerald reported no remaining Pfizer position as of Q3 2025 after selling out during the quarter.
  • Cantor Fitzgerald sold 688 Pfizer shares in Q3 2025, an estimated $16.7K.
  • Cantor Fitzgerald first reported a position in Pfizer in Q2 2022 and held it in 7 quarters.
  • Cantor Fitzgerald's Pfizer position peaked at $64.1M in Q2 2022.
  • 2,811 funds tracked by Wall St. Rank held Pfizer as of Q3 2025.

Based on Cantor Fitzgerald's 13F filing for Q3 2025, filed 14 Nov 2025.